Charles River Labs

A research and testing services company that provides testing for biotech companies, including drug testing on animals.

Why It Works

They serve a large market, as they handle a significant portion of the drug testing process, allowing biotech companies to outsource this critical function.

Revenue & Traction

$4 billion a year in revenue; publicly traded.

Founding Story

Not mentioned in the transcript.

Business Playbook

They control the supply chain by acquiring businesses involved in breeding monkeys to ensure a consistent supply for their testing services.

Why this works now

FDA regulations on animal testing ensure that Charles River Labs remains a critical partner for biotech companies developing new drugs. They could generate initial revenue by promoting their services through the Biotech Showcase, a well-known event that connects investors and biotech firms. A significant risk for the business is the increasing scrutiny and potential changes in animal welfare regulations, which could impact the demand for their testing services and affect compliance costs.

Additional Information

They work with 80% of biotech companies and have a monopoly in the drug testing market.

Source

Podcast: My First Million

Episode: 3 killer businesses hiding in plain sight

Creation Date: August 12, 2026

Ideas worth reading next

More case studies

More case studies from My First Million

See all My First Million coverage →